GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Extrawell Pharmaceutical Holdings Ltd (HKSE:00858) » Definitions » PB Ratio

Extrawell Pharmaceutical Holdings (HKSE:00858) PB Ratio : 0.09 (As of May. 25, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Extrawell Pharmaceutical Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-25), Extrawell Pharmaceutical Holdings's share price is HK$0.038. Extrawell Pharmaceutical Holdings's Book Value per Share for the quarter that ended in Sep. 2023 was HK$0.44. Hence, Extrawell Pharmaceutical Holdings's PB Ratio of today is 0.09.

The historical rank and industry rank for Extrawell Pharmaceutical Holdings's PB Ratio or its related term are showing as below:

HKSE:00858' s PB Ratio Range Over the Past 10 Years
Min: 0.05   Med: 0.33   Max: 4.23
Current: 0.09

During the past 13 years, Extrawell Pharmaceutical Holdings's highest PB Ratio was 4.23. The lowest was 0.05. And the median was 0.33.

HKSE:00858's PB Ratio is ranked better than
99.37% of 955 companies
in the Drug Manufacturers industry
Industry Median: 2 vs HKSE:00858: 0.09

During the past 12 months, Extrawell Pharmaceutical Holdings's average Book Value Per Share Growth Rate was -13.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 3.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 3.10% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 9.80% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Extrawell Pharmaceutical Holdings was 41.10% per year. The lowest was -5.60% per year. And the median was 4.30% per year.

Back to Basics: PB Ratio


Extrawell Pharmaceutical Holdings PB Ratio Historical Data

The historical data trend for Extrawell Pharmaceutical Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Extrawell Pharmaceutical Holdings PB Ratio Chart

Extrawell Pharmaceutical Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.19 0.36 0.18 0.13

Extrawell Pharmaceutical Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.18 0.14 0.13 0.11

Competitive Comparison of Extrawell Pharmaceutical Holdings's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Extrawell Pharmaceutical Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Extrawell Pharmaceutical Holdings's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Extrawell Pharmaceutical Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Extrawell Pharmaceutical Holdings's PB Ratio falls into.



Extrawell Pharmaceutical Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Extrawell Pharmaceutical Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2023)
=0.038/0.435
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Extrawell Pharmaceutical Holdings  (HKSE:00858) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Extrawell Pharmaceutical Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of Extrawell Pharmaceutical Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Extrawell Pharmaceutical Holdings (HKSE:00858) Business Description

Traded in Other Exchanges
N/A
Address
979 King’s Road, Suites 2206-08, 22nd Floor, Devon House, Taikoo Place, Quarry Bay, Hong Kong, HKG
Extrawell Pharmaceutical Holdings Ltd is an investment holding company. The company's operating segment includes Manufacturing; Trading and Gene Development. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the development, manufacture, and sales of pharmaceutical products. Its trading segment is engaged in the marketing and distribution of imported pharmaceutical products. The gene development segment is engaged in the commercial exploitation and development of genome-related technology. Geographically, it derives a majority of its revenue from China.
Executives
Mao Yumin 2201 Interest of corporation controlled by you
Biowindow Gene Development (hong Kong) Limited 2201 Interest of corporation controlled by you
Ease Gold Investments Limited 2201 Interest of corporation controlled by you
Jnj Investments Ltd 2201 Interest of corporation controlled by you
United Gene Group Ltd 2201 Interest of corporation controlled by you
United Gene Holdings Limited 2201 Interest of corporation controlled by you
United Gene International Holdings Group Limited 2101 Beneficial owner
Xie Yi 2201 Interest of corporation controlled by you
Huang Zhenping 2101 Beneficial owner
United Gene Industry Group Limited 2101 Beneficial owner
Chen Xuhua 2202 Interest of your spouse
Cheng Yong 2201 Interest of corporation controlled by you

Extrawell Pharmaceutical Holdings (HKSE:00858) Headlines

No Headlines